Issue 38, 2018

Core/shell upconversion nanoparticles with intense fluorescence for detecting doxorubicin in vivo

Abstract

Doxorubicin (Dox) is a chemotherapy medication used to treat cancer. Herein, we report a rapid and efficient method for detecting Dox in vivo based on a NaGdF4:Yb3+,Er3+@NaYF4 core/shell upconversion nanoparticles (UCNPs) probe. We found that the intensity ratio of green to red emission (IGVRE) bands of the core/shell NaGdF4:Yb3+,Er3+@NaYF4 nanoparticles was sensitive to Dox in blood samples, and drops as the concentration of Dox increases. In addition, the proposed UCNPs probe possessed the advantage that no nanoparticles leaked into the living body, thus overcoming the intrinsic defect (difficulty in removing UCNPs from blood vessels) of the fluorescence resonance energy transfer (FRET) approach. This proposed UCNP probe design and results may provide some guidance for the real-time and efficient detection of Dox, and can be helpful in biomedical applications.

Graphical abstract: Core/shell upconversion nanoparticles with intense fluorescence for detecting doxorubicin in vivo

Associated articles

Article information

Article type
Paper
Submitted
05 Apr 2018
Accepted
17 May 2018
First published
12 Jun 2018
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2018,8, 21505-21512

Core/shell upconversion nanoparticles with intense fluorescence for detecting doxorubicin in vivo

J. Hu, S. Zhan, X. Wu, S. Hu, S. Wu and Y. Liu, RSC Adv., 2018, 8, 21505 DOI: 10.1039/C8RA02928H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements